PERALDO NEIA, CATERINA
PERALDO NEIA, CATERINA
ONCOLOGIA
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor
2021-01-01 Sainas Sainas, Paola Circosta, Noemi Villella, Elena Martino, Agnese Chiara Pippione, Mohammad Houshmand, Marta Giorgis, Valentina Gaidano, Alessandro Cignetti, Caterina Peraldo Neia, Giovanna Chiorino, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli.
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
2014-01-01 Peraldo-Neia C;Cavalloni G;Soster M;Gammaitoni L;Marchiò S;Sassi F;Trusolino L;Bertotti A;Medico E;Capussotti L;Aglietta M;Leone F
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
2012-01-01 Cavalloni G; Peraldo Neia C; Sarotto I; Gammaitoni L; Migliardi G; Soster M; Marchio' Serena; Aglietta M; Leone F.
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
2011-01-01 Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M.
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient
2016-01-01 Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Casorzo, Laura; Dell’Aglio, Carmine; Bernabei, Paola; Chiorino, Giovanna; Aglietta, Massimo; Leone, Francesco
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.
2016-01-01 Cavalloni G; Peraldo-Neia C; Sassi F; Chiorino G; Sarotto I; Aglietta M; Leone F.
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)
2023-01-01 Lombardi, Pasquale; Aimar, Giacomo; Peraldo-Neia, Caterina; Bonzano, Alessandro; Depetris, Ilaria; Fenocchio, Elisabetta; Filippi, Roberto; Quarà, Virginia; Milanesio, Michela; Cavalloni, Giuliana; Gammaitoni, Loretta; Basiricò, Marco; Cagnazzo, Celeste; Ostano, Paola; Chiorino, Giovanna; Aglietta, Massimo; Leone, Francesco
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
2011-01-01 Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F.
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
2014-01-01 Montemurro F;Prat A;Rossi V;Valabrega G;Sperinde J;Peraldo-Neia C;Donadio M;Galván P;Sapino A;Aglietta M;Baselga J;Scaltriti M
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
2016-01-01 Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Chiorino, Giovanna; Sassi, Francesco; Aglietta, Massimo; Leone, Francesco
Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR.
2014-01-01 Peraldo Neia C;Cavalloni G;Balsamo A;Venesio T;Napoli F;Sassi F;Martin V;Frattini M;Aglietta M;Leone F
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer
2024-01-01 Pippione, Agnese Chiara; Kovachka, Sandra; Vigato, Chiara; Bertarini, Laura; Mannella, Iole; Sainas, Stefano; Rolando, Barbara; Denasio, Enrica; Piercy-Mycock, Helen; Romalho, Linda; Salladini, Edoardo; Adinolfi, Salvatore; Zonari, Daniele; Peraldo-Neia, Caterina; Chiorino, Giovanna; Passoni, Alice; Mirza, Osman Asghar; Frydenvang, Karla; Pors, Klaus; Lolli, Marco Lucio; Spyrakis, Francesca; Oliaro-Bosso, Simonetta; Boschi, Donatella
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
2010-01-01 Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F.
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
2018-01-01 Peraldo-Neia, C.; Ostano, P.; Cavalloni, G.; Pignochino, Y.; Sangiolo, D.; De Cecco, L.; Marchesi, E.; Ribero, D.; Scarpa, A.; De Rose, A.M.; Giuliani, A.; Calise, F.; Raggi, C.; Invernizzi, P.; Aglietta, M.; Chiorino, G.; Leone, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor | 2021 | Sainas Sainas, Paola Circosta, Noemi Villella, Elena Martino, Agnese Chiara Pippione, Mohammad Houshmand, Marta Giorgis, Valentina Gaidano, Alessandro Cignetti, Caterina Peraldo Neia, Giovanna Chiorino, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli. | |
| Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. | 2014 | Peraldo-Neia C;Cavalloni G;Soster M;Gammaitoni L;Marchiò S;Sassi F;Trusolino L;Bertotti A;Medico E;Capussotti L;Aglietta M;Leone F | |
| Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. | 2012 | Cavalloni G; Peraldo Neia C; Sarotto I; Gammaitoni L; Migliardi G; Soster M; Marchio' Serena; Aglietta M; Leone F. | |
| Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. | 2011 | Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M. | |
| Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient | 2016 | Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Casorzo, Laura; Dell’Aglio, Carmine; Bernabei, Paola; Chiorino, Giovanna; Aglietta, Massimo; Leone, Francesco | |
| Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation. | 2016 | Cavalloni G; Peraldo-Neia C; Sassi F; Chiorino G; Sarotto I; Aglietta M; Leone F. | |
| Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT) | 2023 | Lombardi, Pasquale; Aimar, Giacomo; Peraldo-Neia, Caterina; Bonzano, Alessandro; Depetris, Ilaria; Fenocchio, Elisabetta; Filippi, Roberto; Quarà, Virginia; Milanesio, Michela; Cavalloni, Giuliana; Gammaitoni, Loretta; Basiricò, Marco; Cagnazzo, Celeste; Ostano, Paola; Chiorino, Giovanna; Aglietta, Massimo; Leone, Francesco | |
| HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib | 2011 | Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F. | |
| Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer | 2014 | Montemurro F;Prat A;Rossi V;Valabrega G;Sperinde J;Peraldo-Neia C;Donadio M;Galván P;Sapino A;Aglietta M;Baselga J;Scaltriti M | |
| Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma | 2016 | Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Chiorino, Giovanna; Sassi, Francesco; Aglietta, Massimo; Leone, Francesco | |
| Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. | 2014 | Peraldo Neia C;Cavalloni G;Balsamo A;Venesio T;Napoli F;Sassi F;Martin V;Frattini M;Aglietta M;Leone F | |
| Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer | 2024 | Pippione, Agnese Chiara; Kovachka, Sandra; Vigato, Chiara; Bertarini, Laura; Mannella, Iole; Sainas, Stefano; Rolando, Barbara; Denasio, Enrica; Piercy-Mycock, Helen; Romalho, Linda; Salladini, Edoardo; Adinolfi, Salvatore; Zonari, Daniele; Peraldo-Neia, Caterina; Chiorino, Giovanna; Passoni, Alice; Mirza, Osman Asghar; Frydenvang, Karla; Pors, Klaus; Lolli, Marco Lucio; Spyrakis, Francesca; Oliaro-Bosso, Simonetta; Boschi, Donatella | |
| Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas | 2010 | Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F. | |
| Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma | 2018 | Peraldo-Neia, C.; Ostano, P.; Cavalloni, G.; Pignochino, Y.; Sangiolo, D.; De Cecco, L.; Marchesi, E.; Ribero, D.; Scarpa, A.; De Rose, A.M.; Giuliani, A.; Calise, F.; Raggi, C.; Invernizzi, P.; Aglietta, M.; Chiorino, G.; Leone, F. |